GRHL1 antibody (Middle Region)

Catalog No. ABIN952629

This anti-GRHL1 antibody is a Rabbit Polyclonal antibody detecting GRHL1 in WB and EIA. Suitable for Human.

Quick Overview for GRHL1 antibody (Middle Region) (ABIN952629)

Target: GRHL1 (Grainyhead-Like 1 (GRHL1))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This GRHL1 antibody is un-conjugated

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Product Details anti-GRHL1 Antibody

Binding Specificity: AA 293-322, Middle Region

Specificity: This antibody recognizes Human GRHL1 / LBP32 (Center).

Purification: Protein A column, followed by peptide affinity purification

Immunogen: KLH conjugated synthetic peptide between 293-322 amino acids from the Central region of Human GRHL1 / LBP32.

Isotype: Ig Fraction

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS containing 0.09 % (W/V) Sodium Azide as preservative

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details for GRHL1

Target: GRHL1 (Grainyhead-Like 1 (GRHL1))

Alternative Name: GRHL1 / LBP32

Background: GRHL1 is a transcription factor. Isoform 1 may function as an activator and isoform 2 as a repressor in tissues where both forms are expressed. May play a role in development. May be involved in epidermal differentiation (By similarity). Binds and transactivates the EN1 promoter.Synonyms: Grainyhead-like protein 1 homolog, MGR, Mammalian grainyhead, NH32, TFCP2L2, Transcription factor CP2-like 2, Transcription factor LBP-32

Molecular Weight: 49kd

Gene ID: 29841

NCBI Accession: NP_937825

Pathways: Regulation of Lipid Metabolism by PPARalpha